Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone-sulfate (DHEAS) and emotional processing - A behavioral and electrophysiological approach

Hormones and Behavior

Volumn 73, Issue , 2015, Pages 94-103

  do Vale, Sónia ^a,b,c   Selinger, Lenka ^a   Martins, João Martin ^b,c   Bicho, Manuel ^b,d   do Carmo, Isabel ^b,c   Escera, Carles ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF LISBON   (Portugal)

^c HOSPITAL DE SANTA MARIA   (Portugal)

^d Rocha Cabral Institute   (Portugal)

Author keywords

Auditory distraction; Cortisol; Dehydroepiandrosterone; Dehydroepiandrosterone reactivity; Dehydroepiandrosterone sulfate; Emotion processing; Event related potentials; Performance

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; PRASTERONE; PRASTERONE SULFATE; HYDROCORTISONE;

ADULT; AMYGDALOID NUCLEUS; ARTICLE; AUDITORY STIMULATION; BODY MASS; BRAIN FUNCTION; CONTROLLED STUDY; ELECTROENCEPHALOGRAPHY; ELECTROOCULOGRAPHY; ELECTROPHYSIOLOGY; EMOTIONALITY; EVENT RELATED POTENTIAL; FEMALE; HIPPOCAMPUS; HORMONAL CONTRACEPTION; HUMAN; HUMAN EXPERIMENT; INSULA; MENSTRUAL CYCLE; NORMAL HUMAN; PRIORITY JOURNAL; PROBABILITY; SALIVA ANALYSIS; SALIVA LEVEL; STATE TRAIT ANXIETY INVENTORY; TISSUE DISTRIBUTION; VISION; VISUAL STIMULATION; ADOLESCENT; BEHAVIOR; BLOOD; ELECTROCARDIOGRAPHY; ELECTROENCEPHALOGRAM; EMOTION; EMOTIONAL INTELLIGENCE; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; REACTION TIME; YOUNG ADULT;

ADOLESCENT; ADULT; BEHAVIOR; BRAIN WAVES; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; ELECTROCARDIOGRAPHY; EMOTIONAL INTELLIGENCE; EMOTIONS; FEMALE; HUMANS; HYDROCORTISONE; REACTION TIME; YOUNG ADULT;

EID: 84937019763     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2015.06.005     Document Type: Article

References (76)

1. Ahn R.S., Lee Y.J., Choi J.Y., Kwon H.B., Chun S.I. Salivary cortisol and DHEA levels in the Korean population: age-related differences, diurnal rhythm, and correlations with serum levels. Yonsei Med. J. 2007, 48(3):379-388.
2. Alhaj H.A., Massey A.E., McAllister-Williams R.H. Effects of DHEA administration on episodic memory, cortisol and mood in healthy young men: a double-blind, placebo-controlled study. Psychopharmacology 2006, 188(4):541-551.
3. Assies J., Visser I., Nicolson N.A., Eggelte T.A., Wekking E.M., Huyser J., Lieverse R., Schene A.H. Elevated salivary dehydroepiandrosterone-sulfate but normal cortisol levels in medicated depressed patients: preliminary findings. Psychiatry Res. 2004, 128:117-122.
4. Balazs Z., Schweizer R.A., Frey F.J., Rohner-Jeanrenaud F., Odermatt A. DHEA induces 11-HSD2 by acting on CCAAT/enhancer-binding proteins. J. Am. Soc. Nephrol. 2008, 19:92-101.
5. Balconi M., Lucchiari C. In the face of emotions: event-related potentials in supraliminal and subliminal facial expression recognition. Genet. Soc. Gen. Psychol. Monogr. 2005, 131(1):41-69.
6. Barrett-Connor E., Edelstein S.L. A prospective study of dehydroepiandrosterone sulfate and cognitive function in an older population: the Rancho Bernardo Study. J. Am. Geriatr. Soc. 1994, 42:420-423.
7. Barrett-Connor E., von Mühlen D., Laughlin G.A., Kripke A. Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: the Rancho Bernardo Study. J. Am. Geriatr. Soc. 1999, 47(6):685-691.
8. Baulieu E.E., Robel P. Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) as neuroactive neurosteroids. Proc. Natl. Acad. Sci. 1998, 95:2089-2091.
9. Beck A.T. Depression: Clinical, Experimental, and Theoretical Aspects 1967, Harper & Row, New York, NY.
10. Bloch M., Schmidt P.J., Danaceau M.A., Adams L.F., Rubinow D.R. Dehydroepiandrosterone treatment of midlife dysthymia. Biol. Psychiatry 1999, 45(12):1533-1541.
11. Boudarene M., Legros J.J., Timsit-Berthier M. Study of the stress response: role of anxiety, cortisol and DHEAs. Encéphale 2002, 28(2):139-146.
12. Braff D.L., Geyer M.A. Sensorimotor gating and schizophrenia. Human and animal model studies. Arch. Gen. Psychiatry 1990, 47:181-188.
13. Braverman E.R., Blum K. P300 (latency) event-related potential: an accurate predictor of memory impairment. Clin. Electroencephalogr. 2003, 34(3):124-139.
14. Braverman E.R., Chen T.J.H., Chen A.L.C., Kerner M.M., Tung H., Waite R.L., Schoolfield J., Blum K. Preliminary investigation of plasma levels of sex hormones and human growth factor(S), and P300 latency as correlates to cognitive decline as a function of gender. BMC Res Notes 2009, 2:126.
15. Campeau S., Liberzon I., Morilak D., Ressler K. Stress modulation of cognitive and affective processes. Stress 2011, 14(5):503-519.
16. Corral M.J., Escera C. Effects of sound location on visual task performance and electrophysiological measures of distraction. Neuroreport 2008, 19(15):1535-1539.
17. do Vale S., Martins J.M., Fagundes M.J., do Carmo I. Dehydroepiandrosterone-sulphate (DHEAS) is related to personality and stress response. Neuro Endocrinol. Lett. 2011, 32(4):442-448.
18. do Vale S., Selinger L., Martins J.M., Gomes A.C., Bicho M., do Carmo I., Escera C. The relationship between dehydroepiandrosterone (DHEA), working memory and distraction - a behavioral and electrophysiological approach. PLoS One 2014, 9(8):e104869.
19. Domínguez-Borràs J., Garcia-Garcia M., Escera C. Emotional context enhances auditory novelty processing: behavioural and electrophysiological evidence. Eur. J. Neurosci. 2008, 28:1199-1206.
20. Domínguez-Borràs J., Trautmann S.A., Erhard P., Fehr T., Herrmann M., Escera C. Emotional context enhances auditory novelty processing in superior temporal gyrus. Cereb. Cortex 2009, 19(7):1521-1529.
21. Dong Y., Zheng P. Dehydroepiandrosterone sulphate: action and mechanism in the brain. J. Neuroendocrinol. 2011, 24:215-224.
22. Dyck M., Loughead J., Kellermann T., Boers F., Gur R.C., Mathiak K. Cognitive versus automatic mechanisms of mood induction differentially activate left and right amygdala. NeuroImage 2011, 54(3):2503-2513.
23. Ekman P., Friesen W.V. Figures of facial affect 1976, Consulting Psychologists Press, Palo Alto, CA.
24. Escera C., Malmierca M.S. The auditory novelty system: an attempt to integrate human and animal research. Psychophysiology 2014, 51(2):111-123.
25. Escera C., Alho K., Winkler I., Näätänen R. Neural mechanisms of involuntary attention to acoustic novelty and change. J. Cogn. Neurosci. 1998, 10:590-604.
26. Escera C., Alho K., Schröger E., Winkler I. Involuntary attention and distractibility as evaluated with event-related brain potentials. Audiol. Neurootol. 2000, 5:151-166.
27. Escera C., Yago E., Corral M.J., Corbera S., Nuñez M.I. Attention capture by auditory significant stimuli: semantic analysis follows attention switching. Eur. J. Neurosci. 2003, 18(8):2408-2412.
28. Fern M., Rose D.P., Fern E.B. Effect of oral contraceptives on plasma androgenic steroids and their precursors. Obstet. Gynecol. 1978, 51(5):541-544.
29. Fichtenholtz H.M., Hopfinger J.B., Graham R., Detwiler J.M., LaBar K.S. Happy and fearful emotion in cues and targets modulate event-related potential indices of gaze-directed attentional orienting. Soc. Cogn. Affect. Neurosci. 2007, 2(4):323-333.
30. Garcia-Garcia M., Domínguez-Borràs J., SanMiguel I., Escera C. Electrophysiological and behavioral evidence of gender differences in the modulation of distraction by the emotional context. Biol. Psychol. 2008, 79(3):307-316.
31. Gibbs T.T., Russek S.J., Farb D.H. Sulfated steroids as endogenous neuromodulators. Pharmacol. Biochem. Behav. 2006, 84(4):555-567.
32. Gil-ad I., Shtaif B., Eshet R., Maayan R., Rehavi M., Weizman A. Effect of dehydroepiandrosterone and its sulfate metabolite on neuronal cell viability in culture. Isr. Med. Assoc. J. 2001, 3:639-643.
33. Goodyer I.M., Herbert J., Altham P.M. Adrenal steroid secretion and major depression in 8- to 16-year-olds, III. Influence of cortisol/DHEA ratio at presentation on subsequent rates of disappointing life events and persistent major depression. Psychol. Med. 1998, 28:265-273.
34. Gotlib I.H., Joormann J. Cognition and depression: current status and future directions. Annu. Rev. Clin. Psychol. 2010, 6:285-312.
35. Imamura M., Prasad C. Modulation of GABA-gated chloride ion influx in the brain by dehydroepiandrosterone and its metabolites. Biochem. Biophys. Res. Commun. 1998, 243(3):771-775.
36. Kaminska M., Harris J., Gijsbers K., Dubrovsky B. Dehydroepiandrosterone sulfate (DHEAS) counteracts decremental effects of corticosterone on dentate gyrus LTP. Implications for depression. Brain Res. Bull. 2000, 52:229-234.
37. Kemp A.H., Silberstein R.B., Armstrong S.M., Nathan P.J. Gender differences in the cortical electrophysiological processing of visual emotional stimuli. NeuroImage 2004, 21(2):632-646.
38. Kim S.B., Hill M., Kwak Y.T., Hampl R., Jo D.H., Morfin R. Neurosteroids: cerebrospinal fluid levels for Alzheimer's disease and vascular dementia diagnostics. J. Clin. Endocrinol. Metab. 2003, 88(11):5199-5206.
39. Komesaroff P.A. Unraveling the enigma of dehydroepiandrosterone: moving forward step by step. Endocrinology 2008, 149(3):886-888.
40. Lacroix C., Fiet J., Benais J.P., Gueux B., Bonete R., Villette J.M., Gourmel B., Dreux C. Simultaneous radioimmunoassay of progesterone, androst-4-enedione, pregnenolone, dehydroepiandrosterone and 17-hydroxyprogesterone in specific regions of human brain. J. Steroid Biochem. 1987, 28:317-325.
41. Luo W., Feng W., He W., Wang N.Y., Luo Y.J. Three stages of facial expression processing: ERP study with rapid serial visual presentation. NeuroImage 2010, 49(2):1857-1867.
42. MacNamara A., Hajcak G. Anxiety and spatial attention moderate the electrocortical response to aversive pictures. Neuropsychologia 2009, 47(13):2975-2980.
43. Majewska M.D. Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance. Prog. Neurobiol. 1992, 38:379-395.
44. Maninger N., Wolkowitz O.M., Reus V.I., Epel E.S., Mellon S.H. Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front. Neuroendocrinol. 2009, 30(1):65-91.
45. Martins J.M., Trinca A., Afonso A., Carreiras F., Falcão J., Nunes J.S., do Vale S., da Costa J.C. Psychoneuroendocrine characteristics of common obesity clinical subtypes. Int. J. Obes. 2001, 25:24-32.
46. Martins J.M., Alves J., Trinca A., Grima B., do Vale S., Vasconcelos T., Riso N., Riscado V., Charneco da Costa J. Personality, brain asymmetry, and neuroendocrine reactivity in two immune-mediated disorders: a preliminary report. Brain Behav. Immun. 2002, 16(4):383-397.
47. Martins J.M., do Vale S., Trinca A., Saldanha C., Martins e Silva J. Personality, brain asymmetry and neuroendocrine reactivity in hirsute subjects. Physiol. Behav. 2004, 82(4):741-749.
48. Martins J.M., do Vale S., Ferreira F., Fagundes M.J., Carmo I., Saldanha C., Martins e Silva J. Plasma corticotropin releasing hormone (CRH) during the feeling of induced emotions. Neuro Endocrinol. Lett. 2010, 31(2):250-255.
49. McEwen B.S. Brain on stress: how the social environment gets under the skin. Proc. Natl. Acad. Sci. 2012, 109(Suppl. 2):17180-17185.
50. Michael A., Jenaway A., Parkel E.S., Herbert J. Altered salivary dehydroepiandrosterone levels in major depression in adults. Biol. Psychiatry 2000, 48(10):989-995.
51. Monnet F.P., Mahé V., Robel P., Baulieu E.E. Neurosteroids, via sigma receptors, modulate the [3H]norepinephrine release evoked by N-methyl-d-aspartate in the rat hippocampus. Proc. Natl. Acad. Sci. U. S. A. 1995, 92(9):3774-3778.
52. Morgan C.A., Rasmusson A., Piertzak R.H., Coric V., Southwick S.M. Relationships among plasma dehydroepiandrosterone and dehydroepiandrosterone sulfate, cortisol, symptoms of dissociation, and objective performance in humans exposed to underwater navigation stress. Biol. Psychiatry 2009, 66(4):334-340.
53. Murray H.E., Gillies G.E. Differential effects of neuroactive steroids on somatostatin and dopamine secretion from primary hypothalamic cell cultures. J. Neuroendocrinol. 1997, 9(4):287-295.
54. Nieschlag E., Loriaux D.L., Ruder H.J., Zucker I.R., Kirschner M.A., Lipsett M.B. The secretion of dehydroepiandrosterone and dehydroepiandrosterone sulphate in man. J. Endocrinol. 1973, 57(1):123-134.
55. Öhman A., Lundqvist D., Esteves F. The face in the crowd revisited: a threat advantage with schematic stimuli. J. Pers. Soc. Psychol. 2001, 80(3):381-396.
56. Polich J. Updating P300: an integrative theory of P3a and P3b. Clin. Neurophysiol. 2007, 118:2128-2148.
57. Rosenfeld R.S., Rosenberg B.J., Fukushima D.K., Hellman L. 24-hour secretory pattern of dehydroepiandrosterone and dehydroepiandrosterone sulfate. J. Clin. Endocrinol. Metab. 1975, 40(5):850-855.
58. Russo S.J., Murrough J.W., Han M.H., Charney D.S., Nestler E.J. Neurobiology of resilience. Nat. Neurosci. 2012, 15(11):1475-1484.
59. Schmidt P.J., Daly R.C., Bloch M., Smith M.J., Danaceau M.A., St Clair L.S., Murphy J.H., Haq N., Rubinow D.R. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression. Arch. Gen. Psychiatry 2005, 62:154-162.
60. Schneider F., Gur R.C., Gur R.E., Muenz L.R. Standardized mood induction with happy and sad facial expressions. Psychiatry Res. 1994, 51:19-31.
61. Schneider F., Grodd W., Weiss U., Klose U., Mayer K.R., Nagele T., Gur R.C. Functional MRI reveals left amygdala activation during emotion. Psychiatry Res. 1997, 76:75-82.
62. Schröger E., Wolff C. Attentional orienting and re-orienting is indicated by human event-related brain potentials. NeuroReport 1998, 9:3355-3358.
63. Schupp H.T., Ohman A., Junghofer M., Weike A.I., Stockburger J., Hamm A.O. The facilitated processing of threatening faces: an ERP analysis. Emotion (Washington, D.C.) 2004, 4(2):189-200.
64. Scott L.V., Salahuddin F., Cooney J., Svec F., Dinan T.G. Differences in adrenal steroid profile in chronic fatigue syndrome, in depression and in health. J. Affect. Disord. 1999, 54:129-137.
65. Slabu L., Escera C., Grimm S., Costa-Faidella J. Early change detection in humans as revealed by auditory brainstem and middle-latency evoked potentials. Eur. J. Neurosci. 2010, 32(5):859-865.
66. Spielberger C.D., Gorsuch R.L., Lushene R.E. Cuestionario de Ansiedad Estado-Rasgo - Manual [Manual for the State-Trait Anxiety Inventory] 1988, TEA Ediciones, S.A., Madrid, (allowed by the original Consulting Psychologists Press, Inc., California, USA). 3rd ed.
67. Sripada R.K., Marx C.E., King A.P., Rajaram N., Garfinkel S.N., Abelson J.L., Liberzon I. DHEA enhances emotion regulation neurocircuits and modulates memory for emotional stimuli. Neuropsychopharmacology 2013, 38(9):1798-1807.
68. van Peer J.M., Roelofs K., Rotteveel M., van Dijk J.G., Spinhoven P., Ridderinkhof K.R. The effects of cortisol administration on approach-avoidance behavior: an event-related potential study. Biol. Psychol. 2007, 76(3):135-146.
69. Vining R.F., McGinley R.A. The measurement of hormones in saliva: possibilities and pitfalls. J. Steroid Biochem. 1987, 27(1-3):81-94.
70. Wang S., Zhao Y., Chen S., Lin G., Sun P., Wang T. EEG biofeedback improves attentional bias in high trait anxiety individuals. BMC Neurosci. 2013, 14:115.
71. Weill-Engerer S., David J.P., Sazdovitch V., Liere P., Eychenne B., Pianos A., Schumacher M., Delacourte A., Baulieu E.E., Akwa Y. Neurosteroid quantification in human brain regions: comparison between Alzheimer's and nondemented patients. J. Clin. Endocrinol. Metab. 2002, 87:5138-5143.
72. Wiegratz I., Kutschera E., Lee J.H., Moore C., Mellinger U., Winkler U.H., Kuhl H. Effect of four different oral contraceptives on various sex hormones and serum-binding globulins. Contraception 2003, 67(1):25-32.
73. Wolf O.T., Neuman O., Hellhammer D.H., Geiben A.C., Strasburger C.J., Dressendörfer R.A., Pirke K.M., Kirschbaum C. Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men. J. Clin. Endocrinol. Metab. 1997, 82(7):2363-2367.
74. Wolkowitz O.M., Reus V.I., Keebler A., Nelson N., Friedland M., Brizendine L., Roberts E. Double-blind treatment of major depression with dehydroepiandrosterone (DHEA). Am. J. Psychiatry 1999, 156:646-664.
75. Yago E., Escera C., Alho K., Giard M.H. Cerebral Mechanisms underlying orienting of attention towards auditory frequency changes. Neuroreport 2001, 12(11):2583-2587.
76. Young A.H., Gallagher P., Porter R.J. Elevation of the cortisol-dehydroepiandrosterone ratio in drug free depressed patients. Am. J. Psychiatry 2002, 159:1237-1239.